AHI Allied Health

 

TIDMAHI 
 
RNS Number : 3027R 
Allied Healthcare International Inc 
19 August 2010 
 

Allied Healthcare International Inc. Announces Changes to Its Board of Directors 
 
NEW YORK, NY--(Marketwire - August 19, 2010) - Allied Healthcare International 
Inc. (NASDAQ: AHCI) (AIM: AHI), a leading provider of flexible healthcare 
staffing services in the United Kingdom, announced today that G. Richard Green 
has tendered his resignation as a member of the Company's Board of Directors for 
personal reasons, effective August 21, 2010. Mr. Green has been a director of 
Allied since 1998 and recently served on the Nominating and Corporate Governance 
Committee of the Board. 
 
The Company also announced that Professor Raymond John Playford has been 
appointed to the Board of Directors of Allied, effective August 21, 2010. Prof. 
Playford, age 50, has served as Medical Advisor to the Board of Allied since 
June 2010. 
 
Dr. Jeffrey S. Peris, Chairman of the Board of Allied Healthcare International 
Inc., commented, "Richard has served with distinction on our Board. His 
intellect, depth of business knowledge and leadership experience have 
contributed greatly to Allied's growth and success throughout his long tenure as 
our director. On behalf of the entire Board, senior management team and 
employees of Allied, we want to wish Richard years of health and happiness." 
 
Dr. Peris also stated, "Ray has already made many valuable contributions since 
he joined us as Medical Advisor, and we welcome him to the Board to further 
assist us in augmenting the growth strategies of our Company. His wealth of 
clinical, healthcare and NHS expertise will both support our commitment to 
providing our customers with one of the highest levels of quality care in our 
industry and to enhancing the market leadership of Allied." 
 
Prof. Playford has more than 25 years of experience in the medical field, 
specializing in clinical research. He is currently Deputy Warden and Professor 
of Medicine at Barts and the London School of Medicine and Dentistry, as well as 
Vice Principal (NHS Liaison), Queen Mary, University of London. Prof. Playford 
is also a Non-Executive Director of Barking, Havering and Redbridge NHS Trust 
and a director of Repair and Protection Foods Ltd., which is engaged in food 
research. He has also been an advisor to both the UK Government and the 
healthcare industry. 
 
Prof. Playford received a Medical degree (M.B., B.S.) in 1978 from St. 
Bartholomew's Medical School and his PhD in 1992 from the Royal Postgraduate 
Medical School at Imperial College, London. He is a Fellow of the Royal College 
of Physicians (UK) and the Royal College of Pathologists (UK) and was Visiting 
Professor, Harvard Medical School and Massachusetts General Hospital in 2002. He 
has published over 100 original scientific and clinical papers and received 
several awards for research including the British Society of Gastroenterology 
(BSG) Sir Francis Avery Jones Research Medal in 1995 and Canadian Alberta 
Heritage Foundation for Medical Research in 2004. He was made a Fellow of the 
Academy of Medical Scientists in 2002 and, as a result of his contribution to 
public education on health matters, became a Fellow of the Royal Society of Arts 
in 2000. 
 
There are no further disclosures regarding Prof. Playford that are required to 
be set forth in this press release under the AIM rules. 
 
About Allied Healthcare International Inc. 
 
Allied Healthcare International Inc. is a leading provider of flexible 
healthcare staffing services in the United Kingdom. Allied operates a 
community-based network of approximately 115 branches with the capacity to 
provide carers (known as home health aides in the U.S.), nurses, and specialized 
medical personnel to locations covering approximately 90% of the U.K. 
population. Allied meets the needs of private patients, community care, nursing 
and care homes, and hospitals. For more news and information please visit: 
www.alliedhealthcare.com. 
 
Forward-Looking Statements 
 
Certain statements contained in this news release may be forward-looking 
statements. These forward-looking statements are based on current expectations 
and projections about future events. Actual results could differ materially from 
those discussed in, or implied by, these forward-looking statements. Factors 
that could cause actual results to differ from those implied by the 
forward-looking statements include: general economic and market conditions; the 
effect of the change in the U.K. government and the impact of proposed changes 
in recent policy making related to health and social care that may reduce 
revenue and profitability; Allied's ability to continue to recruit and retain 
flexible healthcare staff; Allied's ability to enter into contracts with local 
government social services departments, NHS Trusts, hospitals, other healthcare 
facility clients and private clients on terms attractive to Allied; the general 
level of demand for healthcare and social care; dependence on the proper 
functioning of Allied's information systems; the effect of existing or future 
government regulation of the healthcare and social care industry, and Allied's 
ability to comply with these regulations; the impact of medical malpractice and 
other claims asserted against Allied; the effect of regulatory change that may 
apply to Allied and that may increase costs and reduce revenues and 
profitability; Allied's ability to use net operating loss carry forwards to 
offset net income; the effect that fluctuations in foreign currency exchange 
rates may have on our dollar-denominated results of operations; and the 
impairment of goodwill, of which Allied has a substantial amount on the balance 
sheet, may have the effect of decreasing earnings or increasing losses. Other 
factors that could cause actual results to differ from those implied by the 
forward-looking statements in this press release include those described in 
Allied's most recently filed SEC documents, such as its most recent annual 
report on Form 10-K, all quarterly reports on Form 10-Q and any current reports 
on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no 
obligation to publicly update or revise any forward-looking statements, whether 
as a result of new information, future events, or otherwise. 
 
 
CONTACT 
 
 Allied Healthcare International Inc. 
 Sandy Young 
 Chief 
Executive Officer 
 Paul Weston 
 Chief Financial Officer 
 +44 (0) 17 
8581 0600 
 
 Or 
 
 Piper Jaffray Ltd. (Nominated Adviser) 
 Matthew 
Flower 
 Rupert Winckler 
 +44 (0) 20 3142 8700 
 
 Or 
 
 ICR 
Inc. 
 Sherry Bertner 
 Managing Director 
 +1 646 277 
1200 
Sherry.Bertner@icrinc.com 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 BOAFVLLFBVFXBBD 
 

Allied Healthcare (LSE:AHI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024

Allied Healthcare (LSE:AHI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024